|
| |
|
 |
|
|
| [DISPLAY PATENT] |
| |
| |
|
|
| Application no. and date | 00971346.2 (espacenet) (Federated) (European Patent Register), 20001009 | | Patent/reg. no. and date | DK/EP 1223914, 20040901 | | Publication date | 20020724 | | Priority no. and date | EP 99203338, 19991013 | | EP pub. no. and date |
EP 1223914 20020724 | | Effective date | | | Applicant/owner | Merck Sharp & Dohme B.V., Waarderweg 39
2031 BN Haarlem, NL | | Applicant ref. no. | 79525 | | Inventor | DE NIJS, Henrik, Hermelijnedreef 27
NL-5343 XC Oss, NL | | Representative | CHAS. HUDE A/S, Langebrogade 3B, 1411 København K, DK | | Opponent | | | IPC Class | A61K 31/55 (2006.01) , A61K 9/00 (2006.01) | | Title | Oralt desintegrerende sammensætning, der omfatter mirtazapin | | Int. application no. | EP2000009863 | | Int. publication no. | WO2001026621 | | Related patent (certificate) | | | Status | Ophævet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
|
